Physician profile
Deborah Boyd
NPI 1639209190
$368.10
in general payments reported to CMS, 2019-2025
9 companies · $35.95 in 2025
The $35.95 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.11 · 2022: $14.15 · 2023: $68.53 · 2024: $206 · 2025: $35.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $137.15 | 2024 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $80.39 | 2021-2023 | Farxiga |
| Abbvie INC. | $53.12 | 2024 | |
| Optinose US, INC. | $18.33 | 2025 | |
| Abbott Laboratories | $17.62 | 2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $17.22 | 2021 | |
| Exact Sciences Corporation | $16.09 | 2024 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $14.15 | 2022 | |
| Amgen INC. | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.